Healthcare Investment Banking
Founded in 2000, VelocityHealth Securities operates a financial advisory firm and a middle market investment banking firm focused on growth companies within all healthcare sectors including: specialty pharmaceuticals, biotechnology, diagnostics, healthcare information technology (HCIT), healthcare services, medical devices, and generic pharmaceuticals.
VHS offers mergers and acquisitions advisory services for sponsors and companies with enterprise value transactions from $10 million to $500 million, including buy-sides, recapitalizations, sell-sides and fairness opinions. We also advise growth companies with seeking growth capital including equity, subordinated debt, and senior debt. Our typical equity client is seeking between $5 million to $100 million in growth capital.
Additionally, VHS offers advisory services for companies regarding business development and strategic relationships such as: in-licensing and out-licensing of products and technologies, channel partners, and corporate partnering.
VelocityHealth Securities, Inc.
95 White Bridge Road, Suite 409
Nashville, TN 37205 USA
François Ducret joined LaMed Pharma in 2019 to develop our ophthalmic, dermatologic and aesthetic operations in EMEA, APAC and LATAM, using his extensive experience in selling pharmaceuticals, medical devices, food supplements, diagnostic tests and hospital equipments. François is not only bringing his strong expertise in international business (3+ senior management positions with full P&L and budgeting responsibilities at Allergan, Nicox and Visufarma) but also his significant experience in distributor management (15+ years of distributor search, audit and signing, business plans implemented with senior executives, transition from distributor model to direct operations).
Born in 1970 in the French Alps, François has a master’s degree in International Business Development (IAE Savoie Mont-Blanc) and followed executive programs in business administration (HEC – Paris). He lives in the South of France.